Log In
Print
BCIQ
Print
Print this Print this
 

AZD5312, ISIS-AR-2.5Rx (formerly ISIS-ARRx, ISIS-AZ1Rx)

  Manage Alerts
Collapse Summary General Information
Company Isis Pharmaceuticals Inc.
DescriptionAntisense inhibitor of the production of androgen receptor
Molecular Target Androgen receptor
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1,011.5M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today